Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Promoting the inclusion of vital-capacity data in the bronchodilator response

Authors Ben Saad H

Received 31 March 2017

Accepted for publication 3 April 2017

Published 24 April 2017 Volume 2017:12 Pages 1243—1245


Checked for plagiarism Yes

Editor who approved publication: Dr Richard Russell

Helmi Ben Saad

Laboratory of Physiology, Faculty of Medicine of Sousse, University of Sousse, Tunisia

I read with interest the manuscript of Torén et al1 asking for a change in the interpreting way of the reversibility test. The authors have opted for a difference between the predicted normal values after and before bronchodilation (ABD, BBD, respectively).1 They have included three spirometric data (forced expiratory volume in the first second [FEV1], forced vital capacity [FVC] and slow vital capacity [SVC]), and they have proposed three thresholds to be significant at 9, 4 and 6%, respectively, for FEV1, FVC and SVC. Such papers are encouraged since vital-capacity (FVC and SVC) data are still “neglected” by the Global Obstructive Lung Disease (GOLD).2 Moreover, in the GOLD 2017 Report, it was clearly stated that “assessing the degree of reversibility of airflow limitation does not aid the diagnosis of COPD, differentiate COPD from asthma, or predict the long-term response to treatment.”

Author reply
Kjell Torén

Section of Occupational and Environmental Medicine, University of Gothenburg, Gothenburg, Sweden

We appreciate the comments by Dr Ben Saad and take the opportunity to add a few remarks: 1) The difference between the values after bronchodilatation (% predicted normal) minus the value before bronchodilatation (% predicted normal) is rather insensitive to the particular reference equation applied to calculate the predicted normal. 2) The final conclusion by Dr Ben Saad that forced vital capacity and slow vital capacity should be included when assessing the effect of bronchodilatation is quite in line with our opinion.

View original paper by Torén et al

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]